PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Systems pharmacology reveals the mechanism of activity of Physalis alkekengi L. var. franchetii against lipopolysaccharide-induced acute lung injury.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32220053 ↗2020Reported benefit

Systems pharmacology reveals the mechanism of activity of Physalis alkekengi L. var. franchetii against lipopolysaccharide-induced acute lung injury.

MouseEndotoxin/LPSBALB/cMalen = 10 mice per group, four groups (control, LPS model, PAF 500…Oral gavage500 mg/kgPretreatment; LPS was injected 1 hour after the last PAF dose

Model: Acute lung injury induced by a single intraperitoneal injection of lipopolysaccharide (5 mg/kg)

PAF at 500 mg/kg reduced lung histopathological damage and the lung wet/dry ratio, lowered cytokine release including TNF-alpha and accumulation of oxidation products, decreased NF-kappaB, p-p38, ERK, JNK, p53, caspase-3 and COX-2, enhanced nuclear Nrf2 translocation, corrected the energy metabolis…

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.